 | • レポートコード：GIR-107A14886 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、5価アンチモニアルのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。5価アンチモニアルの種類別市場規模（スチボグルコン酸ナトリウム、アンチモン酸メグルミン）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・5価アンチモニアルの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、GlaxoSmithKline、Bristol-Myers Squibb、Maiden Pharmaceuticals、Xinhua Pharm、Albert David、Science Direct ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：スチボグルコン酸ナトリウム、アンチモン酸メグルミン ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・5価アンチモニアルの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・5価アンチモニアルのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・5価アンチモニアルのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・5価アンチモニアルの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・5価アンチモニアルの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pentavalent Antimonials market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pentavalent Antimonials size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Pentavalent Antimonials market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pentavalent Antimonials market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Sodium Stibogluconate
Meglumine Antimoniate
Market segment by Application can be divided into
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Pentavalent Antimonials market are listed below:
Sanofi
GlaxoSmithKline
Bristol-Myers Squibb
Maiden Pharmaceuticals
Xinhua Pharm
Albert David
Science Direct
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Pentavalent Antimonials product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pentavalent Antimonials, with price, sales, revenue and global market share of Pentavalent Antimonials in 2018 and 2019.
Chapter 3, the Pentavalent Antimonials competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pentavalent Antimonials breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Pentavalent Antimonials market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Pentavalent Antimonials sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Pentavalent Antimonials Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pentavalent Antimonials Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Sodium Stibogluconate
1.2.3 Meglumine Antimoniate
1.3 Market Analysis by Application
1.3.1 Overview: Global Pentavalent Antimonials Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Pentavalent Antimonials Market Size & Forecast
1.4.1 Global Pentavalent Antimonials Sales in Value (2016-2026))
1.4.2 Global Pentavalent Antimonials Sales in Volume (2016-2026)
1.4.3 Global Pentavalent Antimonials Price by Type (2016-2026) & (USD/mg)
1.5 Global Pentavalent Antimonials Production Capacity Analysis
1.5.1 Global Pentavalent Antimonials Total Production Capacity (2016-2026)
1.5.2 Global Pentavalent Antimonials Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pentavalent Antimonials Market Drivers
1.6.2 Pentavalent Antimonials Market Restraints
1.6.3 Pentavalent Antimonials Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Pentavalent Antimonials Product and Services
2.1.4 Sanofi Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Pentavalent Antimonials Product and Services
2.2.4 GlaxoSmithKline Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Pentavalent Antimonials Product and Services
2.3.4 Bristol-Myers Squibb Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Maiden Pharmaceuticals
2.4.1 Maiden Pharmaceuticals Details
2.4.2 Maiden Pharmaceuticals Major Business
2.4.3 Maiden Pharmaceuticals Pentavalent Antimonials Product and Services
2.4.4 Maiden Pharmaceuticals Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Xinhua Pharm
2.5.1 Xinhua Pharm Details
2.5.2 Xinhua Pharm Major Business
2.5.3 Xinhua Pharm Pentavalent Antimonials Product and Services
2.5.4 Xinhua Pharm Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Albert David
2.6.1 Albert David Details
2.6.2 Albert David Major Business
2.6.3 Albert David Pentavalent Antimonials Product and Services
2.6.4 Albert David Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Science Direct
2.7.1 Science Direct Details
2.7.2 Science Direct Major Business
2.7.3 Science Direct Pentavalent Antimonials Product and Services
2.7.4 Science Direct Pentavalent Antimonials Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Pentavalent Antimonials Sales by Manufacturer
3.1 Global Pentavalent Antimonials Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pentavalent Antimonials Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pentavalent Antimonials
3.4 Market Concentration Rate
3.4.1 Top 3 Pentavalent Antimonials Manufacturer Market Share
3.4.2 Top 6 Pentavalent Antimonials Manufacturer Market Share
3.5 Global Pentavalent Antimonials Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pentavalent Antimonials Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pentavalent Antimonials Market Size by Region
4.1.1 Global Pentavalent Antimonials Sales in Volume by Region (2016-2026)
4.1.2 Global Pentavalent Antimonials Revenue by Region (2016-2026)
4.2 North America Pentavalent Antimonials Revenue (2016-2026)
4.3 Europe Pentavalent Antimonials Revenue (2016-2026)
4.4 Asia-Pacific Pentavalent Antimonials Revenue (2016-2026)
4.5 South America Pentavalent Antimonials Revenue (2016-2026)
4.6 Middle East and Africa Pentavalent Antimonials Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pentavalent Antimonials Sales in Volume by Type (2016-2026)
5.2 Global Pentavalent Antimonials Revenue by Type (2016-2026)
5.3 Global Pentavalent Antimonials Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pentavalent Antimonials Sales in Volume by Application (2016-2026)
6.2 Global Pentavalent Antimonials Revenue by Application (2016-2026)
6.3 Global Pentavalent Antimonials Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pentavalent Antimonials Sales by Type (2016-2026)
7.2 North America Pentavalent Antimonials Sales by Application (2016-2026)
7.3 North America Pentavalent Antimonials Market Size by Country
7.3.1 North America Pentavalent Antimonials Sales in Volume by Country (2016-2026)
7.3.2 North America Pentavalent Antimonials Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pentavalent Antimonials Sales by Type (2016-2026)
8.2 Europe Pentavalent Antimonials Sales by Application (2016-2026)
8.3 Europe Pentavalent Antimonials Market Size by Country
8.3.1 Europe Pentavalent Antimonials Sales in Volume by Country (2016-2026)
8.3.2 Europe Pentavalent Antimonials Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pentavalent Antimonials Sales by Type (2016-2026)
9.2 Asia-Pacific Pentavalent Antimonials Sales by Application (2016-2026)
9.3 Asia-Pacific Pentavalent Antimonials Market Size by Region
9.3.1 Asia-Pacific Pentavalent Antimonials Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pentavalent Antimonials Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pentavalent Antimonials Sales by Type (2016-2026)
10.2 South America Pentavalent Antimonials Sales by Application (2016-2026)
10.3 South America Pentavalent Antimonials Market Size by Country
10.3.1 South America Pentavalent Antimonials Sales in Volume by Country (2016-2026)
10.3.2 South America Pentavalent Antimonials Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pentavalent Antimonials Sales by Type (2016-2026)
11.2 Middle East & Africa Pentavalent Antimonials Sales by Application (2016-2026)
11.3 Middle East & Africa Pentavalent Antimonials Market Size by Country
11.3.1 Middle East & Africa Pentavalent Antimonials Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pentavalent Antimonials Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pentavalent Antimonials Typical Distributors
12.3 Pentavalent Antimonials Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Pentavalent Antimonials Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pentavalent Antimonials Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Pentavalent Antimonials Product and Services
Table 6. Sanofi Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Pentavalent Antimonials Product and Services
Table 10. GlaxoSmithKline Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 12. Bristol-Myers Squibb Major Business
Table 13. Bristol-Myers Squibb Pentavalent Antimonials Product and Services
Table 14. Bristol-Myers Squibb Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Maiden Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Maiden Pharmaceuticals Major Business
Table 17. Maiden Pharmaceuticals Pentavalent Antimonials Product and Services
Table 18. Maiden Pharmaceuticals Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Xinhua Pharm Basic Information, Manufacturing Base and Competitors
Table 20. Xinhua Pharm Major Business
Table 21. Xinhua Pharm Pentavalent Antimonials Product and Services
Table 22. Xinhua Pharm Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Albert David Basic Information, Manufacturing Base and Competitors
Table 24. Albert David Major Business
Table 25. Albert David Pentavalent Antimonials Product and Services
Table 26. Albert David Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Science Direct Basic Information, Manufacturing Base and Competitors
Table 28. Science Direct Major Business
Table 29. Science Direct Pentavalent Antimonials Product and Services
Table 30. Science Direct Pentavalent Antimonials Sales (g), Price (USD/mg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Pentavalent Antimonials Sales by Manufacturer (2019-2021e) & (g)
Table 32. Global Pentavalent Antimonials Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Pentavalent Antimonials, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Pentavalent Antimonials Production Capacity by Company, (g): 2020 VS 2021
Table 35. Head Office and Pentavalent Antimonials Production Site of Key Manufacturer
Table 36. Pentavalent Antimonials New Entrant and Capacity Expansion Plans
Table 37. Pentavalent Antimonials Mergers & Acquisitions in the Past Five Years
Table 38. Global Pentavalent Antimonials Sales by Region (2016-2021e) & (g)
Table 39. Global Pentavalent Antimonials Sales by Region (2021-2026) & (g)
Table 40. Global Pentavalent Antimonials Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Pentavalent Antimonials Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Pentavalent Antimonials Sales by Type (2016-2021e) & (g)
Table 43. Global Pentavalent Antimonials Sales by Type (2021-2026) & (g)
Table 44. Global Pentavalent Antimonials Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Pentavalent Antimonials Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Pentavalent Antimonials Price by Type (2016-2021e) & (USD/mg)
Table 47. Global Pentavalent Antimonials Price by Type (2021-2026) & (USD/mg)
Table 48. Global Pentavalent Antimonials Sales by Application (2016-2021e) & (g)
Table 49. Global Pentavalent Antimonials Sales by Application (2021-2026) & (g)
Table 50. Global Pentavalent Antimonials Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Pentavalent Antimonials Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Pentavalent Antimonials Price by Application (2016-2021e) & (USD/mg)
Table 53. Global Pentavalent Antimonials Price by Application (2021-2026) & (USD/mg)
Table 54. North America Pentavalent Antimonials Sales by Country (2016-2021e) & (g)
Table 55. North America Pentavalent Antimonials Sales by Country (2021-2026) & (g)
Table 56. North America Pentavalent Antimonials Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Pentavalent Antimonials Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Pentavalent Antimonials Sales by Type (2016-2021e) & (g)
Table 59. North America Pentavalent Antimonials Sales by Type (2021-2026) & (g)
Table 60. North America Pentavalent Antimonials Sales by Application (2016-2021e) & (g)
Table 61. North America Pentavalent Antimonials Sales by Application (2021-2026) & (g)
Table 62. Europe Pentavalent Antimonials Sales by Country (2016-2021e) & (g)
Table 63. Europe Pentavalent Antimonials Sales by Country (2021-2026) & (g)
Table 64. Europe Pentavalent Antimonials Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Pentavalent Antimonials Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Pentavalent Antimonials Sales by Type (2016-2021e) & (g)
Table 67. Europe Pentavalent Antimonials Sales by Type (2021-2026) & (g)
Table 68. Europe Pentavalent Antimonials Sales by Application (2016-2021e) & (g)
Table 69. Europe Pentavalent Antimonials Sales by Application (2021-2026) & (g)
Table 70. Asia-Pacific Pentavalent Antimonials Sales by Region (2016-2021e) & (g)
Table 71. Asia-Pacific Pentavalent Antimonials Sales by Region (2021-2026) & (g)
Table 72. Asia-Pacific Pentavalent Antimonials Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Pentavalent Antimonials Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Pentavalent Antimonials Sales by Type (2016-2021e) & (g)
Table 75. Asia-Pacific Pentavalent Antimonials Sales by Type (2021-2026) & (g)
Table 76. Asia-Pacific Pentavalent Antimonials Sales by Application (2016-2021e) & (g)
Table 77. Asia-Pacific Pentavalent Antimonials Sales by Application (2021-2026) & (g)
Table 78. South America Pentavalent Antimonials Sales by Country (2016-2021e) & (g)
Table 79. South America Pentavalent Antimonials Sales by Country (2021-2026) & (g)
Table 80. South America Pentavalent Antimonials Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Pentavalent Antimonials Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Pentavalent Antimonials Sales by Type (2016-2021e) & (g)
Table 83. South America Pentavalent Antimonials Sales by Type (2021-2026) & (g)
Table 84. South America Pentavalent Antimonials Sales by Application (2016-2021e) & (g)
Table 85. South America Pentavalent Antimonials Sales by Application (2021-2026) & (g)
Table 86. Middle East & Africa Pentavalent Antimonials Sales by Country (2016-2021e) & (g)
Table 87. Middle East & Africa Pentavalent Antimonials Sales by Country (2021-2026) & (g)
Table 88. Middle East & Africa Pentavalent Antimonials Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Pentavalent Antimonials Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Pentavalent Antimonials Sales by Type (2016-2021e) & (g)
Table 91. Middle East & Africa Pentavalent Antimonials Sales by Type (2021-2026) & (g)
Table 92. Middle East & Africa Pentavalent Antimonials Sales by Application (2016-2021e) & (g)
Table 93. Middle East & Africa Pentavalent Antimonials Sales by Application (2021-2026) & (g)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Pentavalent Antimonials Typical Distributors
Table 97. Pentavalent Antimonials Typical Customers
List of Figures
Figure 1. Pentavalent Antimonials Picture
Figure 2. Global Pentavalent Antimonials Sales Market Share by Type in 2020
Figure 3. Sodium Stibogluconate
Figure 4. Meglumine Antimoniate
Figure 5. Global Pentavalent Antimonials Sales Market Share by Application in 2020
Figure 6. Hospitals Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Global Pentavalent Antimonials Market Size, (USD Million) & (g): 2020 VS 2021 VS 2026
Figure 10. Global Pentavalent Antimonials Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Pentavalent Antimonials Sales (2016-2026) & (g)
Figure 12. Global Pentavalent Antimonials Price by Type (2016-2026) & (USD/mg)
Figure 13. Global Pentavalent Antimonials Production Capacity (2016-2026) & (g)
Figure 14. Global Pentavalent Antimonials Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Pentavalent Antimonials Market Drivers
Figure 16. Pentavalent Antimonials Market Restraints
Figure 17. Pentavalent Antimonials Market Trends
Figure 18. Global Pentavalent Antimonials Sales Market Share by Manufacturer in 2020
Figure 19. Global Pentavalent Antimonials Revenue Market Share by Manufacturer in 2020
Figure 20. Pentavalent Antimonials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Pentavalent Antimonials Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Pentavalent Antimonials Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Pentavalent Antimonials Sales Market Share by Region (2016-2026)
Figure 24. Global Pentavalent Antimonials Revenue Market Share by Region (2016-2026)
Figure 25. North America Pentavalent Antimonials Revenue (2016-2026) & (USD Million)
Figure 26. Europe Pentavalent Antimonials Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Pentavalent Antimonials Revenue (2016-2026) & (USD Million)
Figure 28. South America Pentavalent Antimonials Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Pentavalent Antimonials Revenue (2016-2026) & (USD Million)
Figure 30. Global Pentavalent Antimonials Sales Market Share by Type (2016-2026)
Figure 31. Global Pentavalent Antimonials Revenue Market Share by Type (2016-2026)
Figure 32. Global Pentavalent Antimonials Price by Type (2016-2026) & (USD/mg)
Figure 33. Global Pentavalent Antimonials Sales Market Share by Application (2016-2026)
Figure 34. Global Pentavalent Antimonials Revenue Market Share by Application (2016-2026)
Figure 35. Global Pentavalent Antimonials Price by Application (2016-2026) & (USD/mg)
Figure 36. North America Pentavalent Antimonials Sales Market Share by Type (2016-2026)
Figure 37. North America Pentavalent Antimonials Sales Market Share by Application (2016-2026)
Figure 38. North America Pentavalent Antimonials Sales Market Share by Country (2016-2026)
Figure 39. North America Pentavalent Antimonials Revenue Market Share by Country (2016-2026)
Figure 40. United States Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Pentavalent Antimonials Sales Market Share by Type (2016-2026)
Figure 44. Europe Pentavalent Antimonials Sales Market Share by Application (2016-2026)
Figure 45. Europe Pentavalent Antimonials Sales Market Share by Country (2016-2026)
Figure 46. Europe Pentavalent Antimonials Revenue Market Share by Country (2016-2026)
Figure 47. Germany Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Pentavalent Antimonials Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Pentavalent Antimonials Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Pentavalent Antimonials Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Pentavalent Antimonials Revenue Market Share by Region (2016-2026)
Figure 56. China Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Pentavalent Antimonials Sales Market Share by Type (2016-2026)
Figure 63. South America Pentavalent Antimonials Sales Market Share by Application (2016-2026)
Figure 64. South America Pentavalent Antimonials Sales Market Share by Country (2016-2026)
Figure 65. South America Pentavalent Antimonials Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Pentavalent Antimonials Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Pentavalent Antimonials Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Pentavalent Antimonials Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Pentavalent Antimonials Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Pentavalent Antimonials Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
五価アンチモンの世界市場 2019年版：種類別（スティボグルコン酸ナトリウム、アンチモン酸メグルミン）、用途別（病院薬局、小売薬局、オンライン薬局） Scope of the Report: The worldwide market for Pentavalent Antimonials is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Pentavalent Ant…- 皮膚リーシュマニア症治療薬の世界市場 2019年版：種類別（五価アンチモン薬、抗真菌薬、抗リーシュマニア薬/抗菌薬）、用途別（病院薬局、小売薬局、オンライン薬局） Scope of the Report: The worldwide market for Cutaneous Leishmaniasis Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Cutaneous…
- 世界の皮膚型リーシュマニア症治療薬市場 2021：企業別、地域別、種類・用途別 The Cutaneous Leishmaniasis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の皮膚・全身性リーシュマニア症治療薬市場 2021：企業別、地域別、種類・用途別 The Cutaneous and Systemic Leishmaniasis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 世界の調剤医薬品市場 2021：企業別、地域別、種類・用途別 The Compounding Pharmacies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…